The Halifax Group makes Investment in XL Associates

WASHINGTON, DC — November 21, 2011 — The Halifax Group (“Halifax”) announced a new partnership with the management of XL Associates, Inc., a global acquisition, grants and professional services company based in McLean, VA. Since its founding in 1989, XL has become an award-wining provider of professional services supporting a myriad of federal agencies. Terms of… Read more »


Aptiv Solutions Expands Leadership in Medical Device Regulatory Strategy and Clinical Trial Conduct

FOR IMMEDIATE RELEASE Contact: Lesley Keays Phone: (508) 597-5775 Email: inquiry@aptivsolutions.com   Acquires Medical Device Consultants, Inc. RESTON, VA — August 22, 2011 — Aptiv Solutions announced today the acquisition of Medical Device Consultants, Inc. (MDCI), a provider of expert medical device consulting and clinical trial management and execution. Aptiv Solutions is one of the leading providers of clinical trial… Read more »


Aptiv Solutions, SAS Foster Innovative Approaches to Faster, Better Drug Trials

FOR IMMEDIATE RELEASE Contact: Lesley Keays Phone: (508) 597-5775 Email: inquiry@aptivsolutions.com Two Companies Team to Bring Adaptive Clinical Trial Design to Life Science Companies RESTON, VA —  June 20, 2011—Two industry leaders will jointly drive advanced clinical trial design and deployment of adaptive clinical trials. An agreement between Aptiv Solutions, a leader in designing and executing adaptive clinical trials,… Read more »


Aptiv Solutions Announces the Latest Advance in Adaptive Clinical Trials

ADDPLAN 6 Software Introduced with Unique Offer   RESTON, VA — June 15, 2011— Aptiv Solutions, global provider of clinical research services, announced today the latest release of ADDPLAN, Adaptive Designs-Plans and Analysis®. ADDPLAN 6 is the first software package that incorporates multiple comparison procedures for multi-armed adaptive trials, including treatment selection designs, a flexible combination of clinical… Read more »


Aptiv Solutions Announces Official Launch

FOR IMMEDIATE RELEASE CONTACT: Lesley Keays Phone: (508) 597-5775 Email: lesley.keays@aptivsolutions.com A Unique Global Biopharmaceutical and Medical Device Development Services Company Focused on Adaptive Clinical Trials “Accelerating the Possibilities” RESTON, VA — June 1, 2011 — Chairman and CEO Patrick K. Donnelly today announced the official launch of Aptiv Solutions, a global biopharmaceutical and medical device development services… Read more »


Trio Clinical Research Changes Name to Trio Clinical Resourcing, Focuses on Expert Staffing Capabilities

FOR IMMEDIATE RELEASECONTACT: Lesley KeaysPhone: (508) 597-5775Email: inquiry@aptivsolutions.com   RALEIGH, NC — April 13, 2011 — Trio Clinical Research, an Aptiv Solutions company and clinical resourcing organization, today announced it has changed its company name to Trio Clinical Resourcing. The name change underscores the Company’s new, singular focus on its clinical resourcing business to provide expanded recruitment… Read more »


Aptiv Solutions Announces the Creation of an Adaptive Clinical Trials Innovation Center

FOR IMMEDIATE RELEASECONTACT: Gillian DellaCioppaPhone: (508) 597-6238Email: inquiry@aptivsolutions.com   GREAT FALLS, VA — April 6, 2011—Aptiv Solutions, a global biopharmaceutical and medical device development services company, announced today the creation of an Adaptive Clinical Trials Innovation Center. The Innovation Center is comprised of thought leaders who are internationally renowned experts in adaptive trial design, methodology and implementation. The leaders of… Read more »


Aptiv Solutions and Cancer Genetics Form Strategic Partnership Focused On Creating More Effective Clinical Trials in Oncology

FOR IMMEDIATE RELEASE CONTACT: Gillian DellaCioppa Phone: (508) 597-6238 Email: inquiry@aptivsolutions.com Partnership to help biotechnology and pharmaceutical companies bring next generation oncology therapeutics to market in a more targeted and effective manner GREAT FALLS, VA —March 23, 2011 — Aptiv Solutions and Cancer Genetics, Inc. (CGI) have formed a strategic partnership focused on delivering comprehensive solutions to biopharmaceutical and medical… Read more »


Fulcrum Pharma, an Aptiv Solutions company, Announces Strategic Collaboration Agreement with Ricerca Biosciences

FOR IMMEDIATE RELEASE CONTACT: Gillian DellaCioppa Phone: (508) 597-6238 Email: inquiry@aptivsolutions.com GREAT FALLS, VA —  March 3, 2011 — Fulcrum Pharma, an Aptiv Solutions company, a leading provider of drug development consulting and regulatory services, is pleased to announce a strategic partnership with Ricerca Biosciences, an integrated preclinical contract research organization (CRO) providing services to the biopharmaceutical industry. The collaboration provides unique, value-added… Read more »